The economic ministry of Denmark has lowered its GDP forecast for 2025 to 1.4% growth, a decrease of 1.5 percentage points from the previous projection, due to weakened prospects for pharmaceutical giant Novo Nordisk A/S (NYSE: NVS). However, the forecast predicts a rebound in growth to 2.1% in 2026, an increase of 0.7 points. Employment numbers are on the rise, and inflation is expected to remain below 2%. The ministry attributes the downward revision to U.S. tariff hikes impacting exports and global activity, but notes that the EU-U.S. trade framework has helped reduce uncertainty around sales.